Should refractory Kawasaki disease be considered occult macrophage activation syndrome?

Seminars in Arthritis and Rheumatism

Volumn 46, Issue 4, 2017, Pages e17-

  Choi, Ui Yoon ^a   Han, Seung Beom ^a   Lee, Soo Young ^a   Jeong, Dae Chul ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

CHILD; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG INFUSION; HUMAN; INCIDENCE; LABORATORY TEST; LETTER; MACROPHAGE ACTIVATION SYNDROME; MAJOR CLINICAL STUDY; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRACTICE GUIDELINE; PROGNOSIS; REFERENCE VALUE; SYSTEMIC DISEASE; TREATMENT RESPONSE; INFANT;

HUMANS; INFANT; MACROPHAGE ACTIVATION SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME;

EID: 84994793927     PISSN: 00490172     EISSN: 1532866X     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2016.08.007     Document Type: Letter

References (6)

1. [1] Wang, W., Gong, F., Zhu, W., Fu, S., Zhang, Q., Macrophage activation syndrome in Kawasaki disease: more common than we thought?. Semin Arthritis Rheum 44 (2015), 405–410.
2. [2] Han, R.K., Silverman, E.D., Newman, A., McCrindle, B.W., Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 154 (2000), 694–699.
3. [3] Behrens, E.M., Beukelman, T., Paessler, M., Cron, R.Q., Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol 34 (2007), 1133–1138.
4. [4] Egami, K., Muta, H., Ishii, M., Suda, K., Sugahara, Y., Iemura, M., et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 149 (2006), 237–240.
5. [5] Yamamoto, N., Sato, K., Hoshina, T., Kojiro, M., Kusuhara, K., Utility of ferritin as a predictor of the patients with Kawasaki disease refractory to intravenous immunoglobulin therapy. Mod Rheumatol 25 (2015), 898–902.
6. [6] Ravelli, A., Minoia, F., Davì, S., Horne, A.C., Bovis, F., Pistorio, A., et al. 2016 Classification criteria for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a European league against rheumatism/American College of Rheumatology/Paediatric Rheumatology International Trials Organisation Collaborative Initiative. Ann Rheum Dis 75 (2016), 481–489.